Aclarion Stock Today
| ACONW Stock | USD 0.06 0.01 13.38% |
PerformanceGood
| Odds Of DistressHigh
|
Aclarion is selling for under 0.0589 as of the 16th of March 2025; that is 13.38 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.0564. Aclarion has a very high chance of experiencing financial distress in the next few years of operation. However, it had a very good returns during the last 90 days. The performance scores are derived for the period starting the 16th of December 2024 and ending today, the 16th of March 2025. Click here to learn more.
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy in the United States. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California. Aclarion Inc operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. More on Aclarion
Moving together with Aclarion Stock
Moving against Aclarion Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Aclarion Stock Highlights
| President CEO | Brent Ness |
| Business Concentration | Health Care Equipment & Supplies, Health Care Equipment & Services, Health Care, Health Care, Health Care Equipment & Supplies, Health Information Services, Healthcare (View all Sectors) |
| Financial Strength | |
Aclarion (ACONW) is traded on NASDAQ Exchange in USA. It is located in 8181 Arista Place, Broomfield, CO, United States, 80021 and employs 4 people. Aclarion is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company classifies itself under Health Care Equipment & Supplies sector and is part of Health Care industry.
Aclarion has accumulated about 452.53 K in cash with (3.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.5, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Aclarion Probability Of Bankruptcy
Aclarion Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Aclarion market risk premium is the additional return an investor will receive from holding Aclarion long position in a well-diversified portfolio.
| Risk Adjusted Performance | 0.1322 | |||
| Jensen Alpha | 2.49 | |||
| Total Risk Alpha | 4.98 | |||
| Sortino Ratio | 0.1734 |
Aclarion Stock Against Markets
Already Invested in Aclarion?
The danger of trading Aclarion is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aclarion is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aclarion. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aclarion is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Additional Tools for Aclarion Stock Analysis
When running Aclarion's price analysis, check to measure Aclarion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aclarion is operating at the current time. Most of Aclarion's value examination focuses on studying past and present price action to predict the probability of Aclarion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aclarion's price. Additionally, you may evaluate how the addition of Aclarion to your portfolios can decrease your overall portfolio volatility.